Case Report

Published on 08 Dec 2022

Case report: Recurrent lung infections following treatment with pralsetinib for an elderly patient with RET-fusion positive NSCLC

in Cancer Molecular Targets and Therapeutics

Li An
Pengzhi Chen
Junfeng Wang
Xuebing Qin
Tingting Liu
Yanhong Gao
Peng Wang
Dong Zhang
Xiangqun Fang
Zhijian Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1024365

1,752 views
3 citations

Original Research

Published on 08 Dec 2022

Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA

in Cancer Molecular Targets and Therapeutics

Majid Assadi
Reyhaneh Manafi-Farid
Esmail Jafari
Ahmad Keshavarz
GhasemAli Divband
Mohammad Mobin Moradi
Zohreh Adinehpour
Rezvan Samimi
Habibollah Dadgar
Narges Jokar

Frontiers in Oncology

doi 10.3389/fonc.2022.1066926

3,410 views
17 citations

Review

Published on 06 Dec 2022

The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets

in Cancer Molecular Targets and Therapeutics

Gaofeng Li
Qiru Fu
Cong Liu
Yuxi Peng
Jun Gong
Shilan Li
Yan Huang
Haiyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1074307

3,210 views
9 citations

Original Research

Published on 05 Dec 2022

Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells

in Cancer Molecular Targets and Therapeutics

Marco Ponzetti
Argia Ucci
Chiara Puri
Luca Giacchi
Irene Flati
Daria Capece
Francesca Zazzeroni
Alfredo Cappariello
Nadia Rucci
Stefano Falone

Frontiers in Oncology

doi 10.3389/fonc.2022.983254

2,937 views
4 citations

Original Research

Published on 02 Dec 2022

WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma

in Cancer Molecular Targets and Therapeutics

Yu-De Chu
Hui-Fen Liu
Yi-Chen Chen
Chun-Hung Chou
Chau-Ting Yeh

Frontiers in Oncology

doi 10.3389/fonc.2022.996820

2,961 views
3 citations

Systematic Review

Published on 01 Dec 2022

Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma

in Cancer Molecular Targets and Therapeutics

Jiaxun Song
Xiaofeng Yuan
Lianhua Piao
Jiawen Wang
Pu Wang
Ming Zhuang
Jie Liu
Zhiwei Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1072701

1,724 views
3 citations

Original Research

Published on 01 Dec 2022

Targeting H3K27me3 demethylase to inhibit Shh signaling and cholesterol metabolism in medulloblastoma growth

in Cancer Molecular Targets and Therapeutics

Hongshi Deng
Xueli Guo
Na Feng
Yi Luo
Bei Liu
Shuzhen Liu
Jiang I. Wu
Xuanming Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.1057147

2,066 views
1 citation

Original Research

Published on 30 Nov 2022

BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target

in Cancer Molecular Targets and Therapeutics

Vladimir Bezrookove
Imran A. Khan
Mehdi Nosrati
James R. Miller
Sean McAllister
Altaf A. Dar
Mohammed Kashani-Sabet

Frontiers in Oncology

doi 10.3389/fonc.2022.1011173

2,343 views
4 citations

Original Research

Published on 30 Nov 2022

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

in Cancer Molecular Targets and Therapeutics

Sunisa Prasopporn
Orawan Suppramote
Ben Ponvilawan
Chanette Jamyuang
Jantappapa Chanthercrob
Amphun Chaiboonchoe
Pimkanya More-Krong
Kamonchanok Kongsri
Monthira Suntiparpluacha
Rawisak Chanwat

Frontiers in Oncology

doi 10.3389/fonc.2022.1021632

3,055 views
4 citations

Original Research

Published on 30 Nov 2022

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma

in Cancer Molecular Targets and Therapeutics

Zhen Wang
Wanqun Zheng
Zhen Chen
Shilun Wu
Haoxiao Chang
Ming Cai
Heping Cai

Frontiers in Oncology

doi 10.3389/fonc.2022.1055376

3,683 views
5 citations

Review

Published on 30 Nov 2022

The role of microfibrillar‐associated protein 2 in cancer

in Cancer Molecular Targets and Therapeutics

Wanzhen Xu
Manfeng Wang
Yang Bai
Yong Chen
Xiaoshan Ma
Zhiqing Yang
Liyan Zhao
Yunqian Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1002036

2,937 views
6 citations

Brief Research Report

Published on 29 Nov 2022

Combining superselective catheterization and electrochemotherapy: A new technological approach to the treatment of high-flow head and neck vascular malformations

in Cancer Molecular Targets and Therapeutics

Aljosa Krt
Maja Cemazar
Dimitrij Lovric
Gregor Sersa
Crt Jamsek
Ales Groselj

Frontiers in Oncology

doi 10.3389/fonc.2022.1025270

2,205 views
5 citations

Original Research

Published on 29 Nov 2022

Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity

in Cancer Molecular Targets and Therapeutics

Artem Gridnev
Subhajit Maity
Jyoti R. Misra

Frontiers in Oncology

doi 10.3389/fonc.2022.1021823

4,442 views
12 citations

Editorial

Published on 29 Nov 2022

Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance

in Cancer Molecular Targets and Therapeutics

Antonio Giordano
Nadia Rucci
Stefano Falone

Frontiers in Oncology

doi 10.3389/fonc.2022.1101103

744 views

Original Research

Published on 29 Nov 2022

Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy

in Cancer Molecular Targets and Therapeutics

Dan Que
Hongbo Zou
Bijing Mao
Huan Zhang
Wei Liang
Qin Liu
Leiyu Ke
Lijie Guo
Qichao Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.967675

3,774 views
2 citations

Review

Published on 29 Nov 2022

Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects

in Cancer Molecular Targets and Therapeutics

Sijie Tang
Zhongli Ling
Jiajia Jiang
Xiang Gu
Yuzhong Leng
Chaohui Wei
Huiying Cheng
Xiaohua Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1037794

1,934 views
6 citations

Navigation group

Articles

Case report: Recurrent lung infections following treatment with pralsetinib for an elderly patient with RET-fusion positive NSCLC

Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA

The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets

Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells

WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma

Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma

Targeting H3K27me3 demethylase to inhibit Shh signaling and cholesterol metabolism in medulloblastoma growth

BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma

The role of microfibrillar‐associated protein 2 in cancer

Combining superselective catheterization and electrochemotherapy: A new technological approach to the treatment of high-flow head and neck vascular malformations

Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity

Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance

Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy

Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects